Review article · 2026

Targeted degradation of BRD4 by PROTACs: advances in cancer therapy

Yanyun Hong, Xiang Liu, Yanfang Li, Mengting Yu, Caolin Wang, Cunpeng Nie, Shan Xu

Chemical Communications, 62(17), 4869–4888 · Published 3 March 2026 · DOI 10.1039/d5cc05563f

View at the publisherCite this paper

In brief

“Targeted degradation of BRD4 by PROTACs: advances in cancer therapy” is a 2026 review article by Yanyun Hong and 6 co-authors, published in Chemical Communications. OpenAlex counts 5 citations as of 19 November 2026, which puts it in the top 3% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
5
Most cited in
2026 (5)
Field-weighted impact
2.47
References
133
Authors
7

Abstract

the ubiquitin-proteasome system (UPS). This review systematically summarizes developments over the past decade in BRD4-targeting PROTACs for cancer therapy, focusing on ternary complex design optimization, bioorthogonal activation strategies, and innovations in delivery systems. PROTACs facilitate BRD4 ubiquitination and degradation by simultaneously recruiting BRD4 and various E3 ligases, including CRBN, VHL, MDM2, and DCAF. By integrating… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Hong, Y., Liu, X., Li, Y., Yu, M., Wang, C., Nie, C., & Xu, S. (2026). Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications, 62(17), 4869–4888. https://doi.org/10.1039/d5cc05563f

MLA 9

Hong, Yanyun, et al. “Targeted degradation of BRD4 by PROTACs: advances in cancer therapy.” Chemical Communications, vol. 62, no. 17, 2026, pp. 4869–4888. https://doi.org/10.1039/d5cc05563f.

Chicago

Hong, Yanyun, Xiang Liu, Yanfang Li, Mengting Yu, Caolin Wang, Cunpeng Nie, and Shan Xu. 2026. “Targeted degradation of BRD4 by PROTACs: advances in cancer therapy.” Chemical Communications 62 (17): 4869–4888. https://doi.org/10.1039/d5cc05563f.

Harvard

Hong, Y. et al. (2026) ‘Targeted degradation of BRD4 by PROTACs: advances in cancer therapy’, Chemical Communications, 62(17), pp. 4869–4888. doi:10.1039/d5cc05563f.

IEEE

Y. Hong et al., “Targeted degradation of BRD4 by PROTACs: advances in cancer therapy,” Chemical Communications, vol. 62, no. 17, pp. 4869–4888, 2026, doi: 10.1039/d5cc05563f.

BibTeX

@article{hong2026targeted,
  title     = {{Targeted degradation of BRD4 by PROTACs: advances in cancer therapy}},
  author    = {Hong, Yanyun and Liu, Xiang and Li, Yanfang and Yu, Mengting and Wang, Caolin and Nie, Cunpeng and Xu, Shan},
  journal   = {Chemical Communications},
  year      = {2026},
  volume    = {62},
  number    = {17},
  pages     = {4869--4888},
  doi       = {10.1039/d5cc05563f},
  url       = {https://doi.org/10.1039/d5cc05563f}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • BRD4
  • PROTACs
  • targeted protein degradation
  • ubiquitin-proteasome system
  • E3 ubiquitin ligase
  • cereblon
  • VHL
  • MDM2

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Hong, Y., Liu, X., Li, Y., Yu, M., Wang, C., Nie, C., & Xu, S. (2026). Targeted degradation of BRD4 by PROTACs: advances in cancer therapy. Chemical Communications, 62(17), 4869–4888. https://doi.org/10.1039/d5cc05563f

How many times has this paper been cited?

5 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Yanyun Hong, Xiang Liu, Yanfang Li, Mengting Yu, Caolin Wang, Cunpeng Nie, Shan Xu.

What is the DOI of this paper?

10.1039/d5cc05563f, permanently at https://doi.org/10.1039/d5cc05563f. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.